What drove EVERESTO.BO stock down in pre-market trading?

The stock fell on heavy selling with price at **INR 332.35**, a **-16.57%** drop on high volume **66,022.00**. Short-term factors include relative valuation, receivables strain and weak intraday flows on the BSE.

How does Meyka AI view EVERESTO.BO stock right now?

Meyka AI rates EVERESTO.BO **68.34/100** (Grade B, HOLD). The grade blends benchmarks, sector, growth and key metrics, but it is informational and not investment advice.

What price targets and forecasts exist for EVERESTO.BO stock?

Meyka AI's model projects **INR 379.28** monthly (implied **+14.12%**) and **INR 293.75** yearly (implied **-11.61%**) versus the current **INR 332.35**. Forecasts are model-based and not guarantees.

Which metrics should investors watch for EVERESTO.BO stock?

Track PE (**52.17**), EPS (**6.37**), P/B (**4.45**), days sales outstanding (**224.37**) and cash conversion. Also watch volume spikes and BSE filings for catalyst signals.

IN Stocks

EVERESTO.BO Everest Organics BSE down 16.57% pre-market 17 Feb: watch volume

ByDanny Kontos February 17, 2026February 17, 2026

EVERESTO.BO stock opened as a clear pre-market top loser on 17 Feb 2026 after an intraday drop to INR 332.35, down 66.00 or -16.57% from the previous close. Volume has surged to 66,022.00, nearly 24.00 times average, flagging heavy selling interest. Traders on the BSE are watching liquidity and valuation signals as the Healthcare peer group trades at different multiples.